1. Home
  2. GH vs GGG Comparison

GH vs GGG Comparison

Compare GH & GGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$110.09

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Graco Inc.

GGG

Graco Inc.

HOLD

Current Price

$85.90

Market Cap

13.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
GGG
Founded
2011
1926
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
13.8B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GH
GGG
Price
$110.09
$85.90
Analyst Decision
Strong Buy
Buy
Analyst Count
21
2
Target Price
$99.48
$94.00
AVG Volume (30 Days)
1.9M
736.8K
Earning Date
02-19-2026
01-26-2026
Dividend Yield
N/A
1.39%
EPS Growth
N/A
3.48
EPS
N/A
2.93
Revenue
$902,569,000.00
$2,192,120,000.00
Revenue This Year
$35.00
$6.75
Revenue Next Year
$26.80
$4.83
P/E Ratio
N/A
$29.09
Revenue Growth
30.38
2.85
52 Week Low
$34.80
$72.06
52 Week High
$113.91
$89.67

Technical Indicators

Market Signals
Indicator
GH
GGG
Relative Strength Index (RSI) 63.59 62.50
Support Level $106.42 $82.54
Resistance Level $113.91 $85.03
Average True Range (ATR) 3.97 1.46
MACD 0.63 0.21
Stochastic Oscillator 77.16 92.10

Price Performance

Historical Comparison
GH
GGG

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About GGG Graco Inc.

Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.1 billion in sales in 2024.

Share on Social Networks: